Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis

Farabi Eye Hospital

Status and phase: Unknown; Phase 2; Phase 1

Conditions: Adenoviral Keratoconjunctivitis

Treatments: Drug: Povidone Ophthalmic

Study type: Interventional

Funder types: Other

Identifiers

NCT04041856

farabieyehospital

Details and patient eligibility

About

Povidone-iodine 2% eye drop versus artificial tear drop for treatment of adenoviral keratoconjunctivitis

Full description

Diagnosed EKC patients will be devided into two groups,first group will undergo povidone-iodine 2% eye drop four times a day and the control group will be treated only by artificial tear drops,they will be examined 3 months later and evaluations and data collections for the final comparison will be done.

Enrollment: 200 estimated patients

Sex: All

Ages: 17+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients suspected for viral conjunctivitis

Exclusion criteria

• Allergic to iodized materials
• Age under 17

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

200 participants in 2 patient groups

EKC patients

Active Comparator group

Description:

Povidone-iodine 2% eye drop will be prescribed four times a day All patients will learn how to improve the hygiene level in order to reduce transmission

Treatment:

Drug: Povidone Ophthalmic

Control group

No Intervention group

Description:

All patients will undergo observational treatments including artificial tear drop and improving hygiene level